SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
2.380
-0.225 (-8.64%)
Nov 20, 2026, 4:00 PM EST - Market closed
SCYNEXIS Revenue
SCYNEXIS had revenue of $17.44M in the twelve months ending September 30, 2026, up 494.71% year-over-year. In the year 2025, SCYNEXIS had annual revenue of $41.20M with 449.95% growth. That makes SCYNEXIS the 34,264th largest company in the world by revenue and 4,495th in the United States.
Revenue (ttm)
$17.44M
Revenue Growth
+494.71%
P/S Ratio
1.25
Revenue / Employee
$1,048,944
Employees
18
Market Cap
23.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 41.20M | 33.71M | 449.95% |
| Dec 31, 2024 | 7.49M | -272.79M | -97.33% |
| Dec 31, 2023 | 280.28M | 270.10M | 2,652.72% |
| Dec 31, 2022 | 10.18M | -16.14M | -61.32% |
| Dec 31, 2021 | 26.33M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 121.00K | -136.00K | -52.92% |
| Dec 31, 2018 | 257.00K | - | - |
| Dec 31, 2017 | 257.00K | - | - |
| Dec 31, 2016 | 257.00K | - | - |
| Dec 31, 2015 | 257.00K | -999.00K | -79.54% |
| Dec 31, 2014 | 1.26M | -15.60M | -92.55% |
| Dec 31, 2013 | 16.86M | 20.00K | 0.12% |
| Dec 31, 2012 | 16.84M | -9.62M | -36.35% |
| Dec 31, 2011 | 26.45M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| InterCure | 84.76M |
| Rockwell Medical | 72.58M |
| Aytu BioPharma | 58.52M |
| Biofrontera | 48.26M |
| China Pharma Holdings | 4.31M |
| TherapeuticsMD | 3.75M |
| Akanda | 662.47K |
| Incannex Healthcare | 12.00K |
SCYX News
- 12 days ago - SCYNEXIS Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 13 days ago - SCYNEXIS Slides: Corporate presentation - Filings
- 17 days ago - Scynexis reports Q3 EPS (71c), consensus (72c) - TheFly
- 17 days ago - Scynexis files $200M mixed securities shelf - TheFly
- 17 days ago - SCYNEXIS Reports Third Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 17 days ago - SCYNEXIS Quarterly report: Q3 2026 - Filings
- 17 days ago - SCYNEXIS Earnings release: Q3 2026 - Filings
- 17 days ago - SCYNEXIS Registration statement: Registration filing - Filings